FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Clears Cutera Laser for Tattoo Removal

[ Price : $8.95]

FDA clears a Cutera 510(k) for its Enlighten laser system for tattoo removal.

FDA Panel Rejects Novartis Multiple Myeloma Drug

[ Price : $8.95]

FDAs Oncologic Drugs Advisory Committee votes 5 to 2 not to recommend approval for Novartis panobinostat, a pan-deacetylase (pan-D...

Advocacy Groups Ask Stronger Chantix Warning

[ Price : $8.95]

Five consumer advocacy groups ask FDA for stronger labeling to describe adverse events associated with Pfizers Chantix.

Pediatric Subcommittee to Discuss 3 Cancer Therapies

[ Price : $8.95]

Federal Register Notice: FDAs Pediatric Oncology Subcommittee will meet 12/11 to discuss pediatric development plans for three pro...

Support Voiced for Duchenne Muscular Dystrophy Guidance

[ Price : $8.95]

Comments offer suggestions to strengthen a proposed FDA draft guidance on drug development to treat Duchenne muscular dystrophy.

FDA Grants Orphan Drug to Merrimack for Pancreatic Cancer Drug

[ Price : $8.95]

FDA grants orphan drug designation to Merrimack Pharmaceuticalss for its drug candidate MM-141 for treating pancreatic cancer.

Comments Sought on Clinical Trial Regs

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on clinical investigation regulations for the safety and effectiveness of unapproved d...

Bio-Rad Labs Pays $14 Mil. Over Illegal Sales to Russia

[ Price : $8.95]

Bio-Rad Laboratories agrees to pay a $14.35 million penalty to resolve allegations that it violated the Foreign Corrupt Practices ...

FDA Guidance on Generic Concerta Bioequivalence

[ Price : $8.95]

FDA posts a draft guidance on Bioequivalence Recommendations for Concerta (methylphenidate hydrochloride) extended-release tablets...

Novo Nordisk Reports Positive Weight Loss Data with Liraglutide

[ Price : $8.95]

Novo Nordisk announces new data from its Phase 3a SCALE obesity and pre-diabetes trial that showed 92% of participants lost weight...